The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
BACKGROUND: Low muscle mass and weakness are common and potentially disabling in older adults, but in order to become recognized as a clinical condition, criteria for diagnosis should be based on clinically relevant thresholds and independently validated. The Foundation for the National Institutes of Health Biomarkers Consortium Sarcopenia Project used an evidence-based approach to develop these criteria. Initial findings were presented at a conference in May 2012, which generated recommendations that guided additional analyses to determine final recommended criteria. Details of the Project and its findings are presented in four accompanying manuscripts. METHODS: The Foundation for the National Institutes of Health Sarcopenia Project used data from nine sources of community-dwelling older persons: Age, Gene/Environment Susceptibility-Reykjavik Study, Boston Puerto Rican Health Study, a series of six clinical trials, Framingham Heart Study, Health, Aging, and Body Composition, Invecchiare in Chianti, Osteoporotic Fractures in Men Study, Rancho Bernardo Study, and Study of Osteoporotic Fractures. Feedback from conference attendees was obtained via surveys and breakout groups. RESULTS: The pooled sample included 26,625 participants (57% women, mean age in men 75.2 [±6.1 SD] and in women 78.6 [±5.9] years). Conference attendees emphasized the importance of evaluating the influence of body mass on cutpoints. Based on the analyses presented in this series, the final recommended cutpoints for weakness are grip strength <26kg for men and <16kg for women, and for low lean mass, appendicular lean mass adjusted for body mass index <0.789 for men and <0.512 for women. CONCLUSIONS: These evidence-based cutpoints, based on a large and diverse population, may help identify participants for clinical trials and should be evaluated among populations with high rates of functional limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The separate criteria for muscle mass and strength implied the need to target interventions for individuals with low mass or low strength.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [182]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently, there is no international consensus on the operational definition of sarcopenia, and several definitions of sarcopenia are used with consequent impact on the prevalence of sarcopenia [6,[31][32][33][34].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, a major reason for the variation in sarcopenic obesity prevalence is the method of adjusting muscle quantity for body size.46,47,55,57”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenia, a decrease in muscle mass and/or function, is frequent in undernourished patients admitted to the ICU [21].”
From ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project182 suggested a causal, indirect relationship between muscle mass and function in their definition of sarcopenia.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [182]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Gait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558 · cited 1×
“8 m/s because it predicts reduced overall survival (13), disability (14), and has been recommended by other experts (15).”
BackgroundSelf-citationEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“The definition proposed for sarcopenia was a ratio of muscle mass to height 2 SDs below the mean found in healthy young persons drawn from the Rosetta Stone project (37).”
BackgroundFollow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 3×
“Walking courses that were longer or shorter were converted to a speed that would have been achieved on a 4- or 6-m course using previously published equations (33).”
BackgroundMethodInfluentialSelf-citationEpidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148 · cited 1×
“—In 1948, the Framingham Heart Study (FHS) Original cohort recruited two thirds of the population sample from Framingham, Massachusetts, to evaluate risk factors of heart disease (24).”
BackgroundAbellan Van Kan, G., Rolland, Y., Andrieu, S., Bauer, J., Beauchet, O., Bonnefoy, M., Cesari, M., Donini, L. M., Gillette-Guyonnet, S., Inzitari, M., et al. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0246-z · Cited by 2,003 · cited 1×
“8 m/s because it predicts reduced overall survival (13), disability (14), and has been recommended by other experts (15).”
BackgroundNewman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692 · cited 1×
“entirely consistent, the weight of evidence in communitydwelling older adults suggests that (i) low muscle mass is associated with weakness (3), (ii) weakness (now often referred to as “dynapenia”) (4) is strongly associated with function and disability (5,6), but (iii) low muscle mass alone is weakly or not associate…”
BackgroundSelf-citationAN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645 · cited 1×
“In 1971, adult children of the FHS Original cohort were recruited to the FHS Offspring cohort to understand familial risk factors of heart disease (25).”
MethodVisser, M., Goodpaster, B. H., Kritchevsky, S. B., Newman, A. B., Nevitt, M., Rubin, S. M., Simonsick, E. M., Harris, T. B., & Study, F. T. H. A. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.3.324 · Cited by 1,403 · cited 1×
“entirely consistent, the weight of evidence in communitydwelling older adults suggests that (i) low muscle mass is associated with weakness (3), (ii) weakness (now often referred to as “dynapenia”) (4) is strongly associated with function and disability (5,6), but (iii) low muscle mass alone is weakly or not associate…”
BackgroundSelf-citationSarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981 · cited 1×
“entirely consistent, the weight of evidence in communitydwelling older adults suggests that (i) low muscle mass is associated with weakness (3), (ii) weakness (now often referred to as “dynapenia”) (4) is strongly associated with function and disability (5,6), but (iii) low muscle mass alone is weakly or not associate…”
BackgroundSelf-citationVisser, M., Kritchevsky, S. B., Goodpaster, B. H., Newman, A. B., Nevitt, M., Stamm, E., & Harris, T. B. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50217.x · Cited by 845 · cited 1×
“entirely consistent, the weight of evidence in communitydwelling older adults suggests that (i) low muscle mass is associated with weakness (3), (ii) weakness (now often referred to as “dynapenia”) (4) is strongly associated with function and disability (5,6), but (iii) low muscle mass alone is weakly or not associate…”
BackgroundSelf-citationClark, B. C., & Manini, T. M. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.829 · Cited by 835 · cited 1×
“entirely consistent, the weight of evidence in communitydwelling older adults suggests that (i) low muscle mass is associated with weakness (3), (ii) weakness (now often referred to as “dynapenia”) (4) is strongly associated with function and disability (5,6), but (iii) low muscle mass alone is weakly or not associate…”
BackgroundThe Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Kompendium der Lipid-Studien · doi:10.1007/978-3-642-95642-3_25 · Cited by 831
Ferrucci, L., Bandinelli, S., Benvenuti, E., Di Iorio, A., Macchi, C., Harris, T. B., & Guralnik, J. M. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03873.x · Cited by 804 · cited 1×
“—In 1998–1999, 1,154 men and women aged 65 and older were recruited from populationbased registries in two Italian towns (Bagno a Ripoli in Tuscany and Greve in Chianti) to study subsystems affecting walking ability (27).”
BackgroundSelf-citationOrwoll, E., Blank, J. B., Barrett-Connor, E., Cauley, J., Cummings, S., Ensrud, K., Lewis, C., Cawthon, P. M., Marcus, R., Marshall, L. M., et al. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.05.006 · Cited by 765 · cited 1×
“clinical centers (Birmingham, Alabama; Minneapolis, Minnesota; Palo Alto, California; Monongahela Valley, near Pittsburgh, Pennsylvania; Portland, Oregon; and San Diego, California) to evaluate the epidemiology of osteoporosis and fractures (28,29).”
BackgroundSelf-citationAge, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics
Harris, T. B., Launer, L. J., Eiriksdottir, G., Kjartansson, O., Jonsson, P. V., Sigurdsson, G., Thorgeirsson, G., Aspelund, T., Garcia, M. E., Cotch, M. F., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk115 · Cited by 592 · cited 1×
“— In 2002–2006, adults aged ≥65 years who originally participated in the Reykjavik Study (1967–1997) were recruited to participate in an interdisciplinary genetic epidemiology study of the musculoskeletal, body composition, neurocognitive, and vascular systems including assessment of function by both self-report and p…”
MethodSelf-citationOverview of recruitment for the osteoporotic fractures in men study (MrOS)
Blank, J. B., Cawthon, P. M., Carrion-Petersen, M. L., Harper, L., Johnson, J. P., Mitson, E., & Delay, R. R. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.05.005 · Cited by 573 · cited 1×
“clinical centers (Birmingham, Alabama; Minneapolis, Minnesota; Palo Alto, California; Monongahela Valley, near Pittsburgh, Pennsylvania; Portland, Oregon; and San Diego, California) to evaluate the epidemiology of osteoporosis and fractures (28,29).”
BackgroundSelf-citationGrip Strength Cutpoints for the Identification of Clinically Relevant Weakness
Alley, D. E., Shardell, M. D., Peters, K. W., McLean, R. R., Dam, T.-T. L., Kenny, A. M., Fragala, M. S., Harris, T. B., Kiel, D. P., Guralnik, J. M., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu011 · Cited by 535 · cited 5×
“The second manuscript in the series focuses on developing clinically relevant criteria for weakness based on grip strength (9); the third on criteria for low muscle mass (10); the fourth on longitudinal predictions based on the weakness and muscle mass criteria (11); and the fifth presents comparisons between the FNIH…”
BackgroundInfluentialSelf-citationNewman, A. B., Haggerty, C. L., Goodpaster, B., Harris, T., Kritchevsky, S., Nevitt, M., Miles, T. P., Visser, M., & The Health, A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51105.x · Cited by 505 · cited 1×
“25 mile and climbing a flight of stairs and were free of disability in activities of daily living were recruited at two clinical centers (Memphis, Tennessee and Pittsburgh, Pennsylvania) to evaluate whether change in body composition is a common pathway contributing to disability (26).”
MethodSelf-citationMcLean, R. R., Shardell, M. D., Alley, D. E., Cawthon, P. M., Fragala, M. S., Harris, T. B., Kenny, A. M., Peters, K. W., Ferrucci, L., Guralnik, J. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu012 · Cited by 475 · cited 2×
“The second manuscript in the series focuses on developing clinically relevant criteria for weakness based on grip strength (9); the third on criteria for low muscle mass (10); the fourth on longitudinal predictions based on the weakness and muscle mass criteria (11); and the fifth presents comparisons between the FNIH…”
BackgroundSelf-citationKenny, A. M., Prestwood, K. M., Gruman, C. A., Marcello, K. M., & Raisz, L. G. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.m266 · Cited by 456
Adiposity, Muscle Mass, and Muscle Strength in Relation to Functional Decline in Older Persons
Schaap, L. A., Koster, A., & Visser, M. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs006 · Cited by 423 · cited 3×
“547 Journals of Gerontology: MEDICAL SCIENCES Cite journal as: J Gerontol A Biol Sci Med Sci 2014 May;69(5):547–558 doi:10.”
BackgroundInfluentialVisser, M., Fuerst, T., Lang, T., Salamone, L., Harris, T. B., Health, F. T., Absorptiometry, A., & Group, B. C. W. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.4.1513 · Cited by 422 · cited 1×
“—Total body fat mass and total bonefree lean mass (kg) were acquired from total body scans using fan-beamed dual-energy x-ray absorptiometry (Hologic, Waltham, MA or Lunar, Madison, WI) using standardized protocols (35,36).”
MethodSelf-citationCawthon, P. M., Peters, K. W., Shardell, M. D., McLean, R. R., Dam, T.-T. L., Kenny, A. M., Fragala, M. S., Harris, T. B., Kiel, D. P., Guralnik, J. M., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu023 · Cited by 388 · cited 4×
“Although longitudinal analyses are superior to crosssectional analyses for questions related to causation and prognosis, we note that cross-sectional analyses as used here for our work on grip strength and lean mass cutpoints (9,10) are most appropriate for establishing clinical diagnostic cutpoints based on concurren…”
BackgroundInfluentialSelf-citationAn evidence-based comparison of operational criteria for the presence of sarcopenia
Dam, T.-T., Peters, K. W., Fragala, M., Cawthon, P. M., Harris, T. B., McLean, R., Shardell, M., Alley, D. E., Kenny, A., Ferrucci, L., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu013 · Cited by 363
Self-citationEpidemiology and consequences of sarcopenia
Abellan Van Kan, G. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0201-z · Cited by 344 · cited 1×
“THE term “sarcopenia” originally referred solely to the loss of muscle mass with age, and as such, is an almost universal phenomenon (1,2).”
BackgroundVisser, M., & Schaap, L. A. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.006 · Cited by 320 · cited 1×
“THE term “sarcopenia” originally referred solely to the loss of muscle mass with age, and as such, is an almost universal phenomenon (1,2).”
BackgroundSarcopenia in elderly men and women
Castillo, E. M., Goodman-Gruen, D., Kritz-Silverstein, D., Morton, D. J., Wingard, D. L., & Barrett-Connor, E. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00197-1 · Cited by 290 · cited 1×
“—In 1972, 6,728 men and women aged 30–79 years were recruited from a southern California community (Rancho Bernardo, California) to evaluate the risk factors for heart disease (30).”
BackgroundBone Mineral Density and the Risk of Incident Nonspinal Fractures in Black and White Women
Cauley, J. A. (2005) · JAMA · doi:10.1001/jama.293.17.2102 · Cited by 274 · cited 1×
“In 1997–1998, 662 African American women were additionally recruited (32).”
BackgroundKenny, A. M., Kleppinger, A., Annis, K., Rathier, M., Browner, B., Judge, J. O., & McGee, D. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02865.x · Cited by 252
Self-citationMeasurement of fat mass using DEXA: a validation study in elderly adults
Salamone, L. M., Fuerst, T., Visser, M., Kern, M., Lang, T., Dockrell, M., Cauley, J. A., Nevitt, M., Tylavsky, F., & Lohman, T. G. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.345 · Cited by 233
Tucker, K. L., Mattei, J., Noel, S. E., Collado, B. M., Mendez, J., Nelson, J., Griffith, J., Ordovas, J. M., & Falcon, L. M. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-107 · Cited by 228 · cited 1×
“—In 2004–2007, 1,505 men and women aged 45–75 years and living in Massachusetts were recruited to examine the relationships between life stressors and physical and psychosocial health (17).”
BackgroundPrestwood, K. M., Kenny, A. M., Kleppinger, A., & Kulldorff, M. (2003) · JAMA · doi:10.1001/jama.290.8.1042 · Cited by 200
Kenny, A. M., Biskup, B., Robbins, B., Marcella, G., & Burleson, J. A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51561.x · Cited by 176
Grip Strength and Hand Position of the Dynamometer in 204 Finnish Adults
HÄRKÖNEN, R., PIIRTOMAA, M., & ALARANTA, H. (1993) · Journal of Hand Surgery · doi:10.1016/0266-7681(93)90212-x · Cited by 159 · cited 1×
“Most studies used a Jamar dynamometer (Sammons Preston Rolyan, Bolingbrook, IL) (34).”
MethodHutchins-Wiese, H. L., Kleppinger, A., Annis, K., Liva, E., Lammi-Keefe, C. J., Durham, H. A., & Kenny, A. M. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0415-3 · Cited by 133
Kenny, A. M., Boxer, R. S., Kleppinger, A., Brindisi, J., Feinn, R., & Burleson, J. A. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03019.x · Cited by 125
Home-based resistance training improves femoral bone mineral density in women on hormone therapy
Judge, J. O., Kleppinger, A., Kenny, R. A., Smith, J., Biskup, B., & Marcella, G. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1816-x · Cited by 57
Cited by
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
“…kg Dodds (2014) [26] Chair stand >15 s for five rises Cesari (2009) [67] EWGSOP2 sarcopenia cut-off points for low muscle quantity ASM <20 kg <15 kg Studenski (2014) [3] ASM/height2 <7.0 kg/m2 <6.0 kg/m2 Gould (2014) [125] EWGSOP2 sarcopenia cut-off points for low performance Gait speed ≤0.8 m/s…”
BackgroundInfluentialCruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.002 · Cited by 3,022
“…of recommended cut-off values for muscle mass reductions, GLIM refers to recommendations from the European Working Group on Sarcopenia in Older People (EWGSOP) [15] and from The Foundation of National Institute of Health (FNIH) initiative [16], and the Asian Working Group on Sarcopenia (AWGS) [17].”
BackgroundMethodESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
“Sarcopenia is defined as a decrease in muscle loss and/or function and is frequent in undernourished patients admitted to the ICU [27].”
Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A. J. S., et al. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12383 · Cited by 1,724
“Assessment of muscle strength should be an integral measure in assessment of patients with suspected sarcopenia since impairment of muscle strength is now recognized as a key component for diagnosis of sarcopenia.(15,16) Though inflammatory mediators and other mechanisms besides malnutrition are at play, it is recomme…”
Background
Metadata
- Authors
- Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., Kiel, D. P., Kritchevsky, S. B., Shardell, M. D., Dam, T.-T. L., & Vassileva, M. T.
- Affiliations
- University of Pittsburgh (US)
- California Pacific Medical Center (US)
- University of Maryland, Baltimore (US)
- Beth Israel Deaconess Medical Center (US)
- National Institutes of Health (US)
- University of Central Florida (US)
- Wake Forest University Health Sciences (US)
- Columbia University (US)
- Foundation for the National Institutes of Health (US)
- Corresponding author
- Studenski, Stephanie A.
- ORCID
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-31
- Volume
- 69
- Issue
- 5
- Pages
- 547-558
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- PMC
- PMC3991146
- OpenAlex
- W2156791190
- Cited by
- 2,545
- References
- 41
- Citations by year
- 2026: 186 · 2025: 315 · 2024: 270 · 2023: 254 · 2022: 257 · 2021: 272 · 2020: 246 · 2019: 206 · 2018: 195 · 2017: 138 · 2016: 86 · 2015: 85 · 2014: 29
- FWCI
- 74.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- The Journals of Gerontology Series A (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Journal of International Crisis and Risk Communication Research (submittedVersion)
- Funders
- Foundation for the National Institutes of Health (N01‐HC 25195, N01-AG-12100, P30 AG024827)
- Patrick and Catherine Weldon Donaghue Medical Research Foundation
- Amgen
- Eli Lilly and Company
- Ministero della Salute (263 MD 9164 13, N01-AG-916413, 263 MD 821336, N01-AG-821336, 263 MD 9164)
- Syddansk Universitet
- Hjartavernd (N01-AG-1-2100)
- National Institutes of Health (N01-AG-6-2103, n01ag12100-57-0-2, N01-AG-916413, N01‐AG‐6‐2106, 263MD9164, 1u13ag041583-01, N01-AG-6-2101, n01hc25195-41-0-1, 263 MD 821336, N01-AG-821336, AR/AG41398)
- University of California, San Diego
- National Institute on Aging (N01‐AG‐6–2101, 263 MD 9164, R37AG007181, R01AG005394, N01AG-821336, DK31801, 263-MD-9164-13, 5P60AG13631, AG005407, 821336, 1U13AG041583, N01[AG]916413, N01-AG12100, N01-AG012100, AG027576, R01AR/AG 41398, AR/AG 41398, U01 AR45580, 263MD821336, U01-AG-18197, AG07181, N01-HC-25195, AG 024827, AG-6-2106, AG-6-2103, R01‐AR‐35584, R01AG018887, AG005394, U01AG018197, R01AG005407, R01 AR35583, U01 AR45632, U01AG027810, R01AG027576, P01AG023394, 916413, U01 AR45654, AG18197, R01AG007181, R01AG027087, U01 AR45614, AG-6-2101, AG028507, R01 AG18887, R01‐AR‐35582, U13 AG041583, N01AG62106, AG027574, U01 AR45583, AG027810, R01AG028507, U01 AR45647, AG41398, N01-AG-62103, R01AG027574, P30AG024827)
- National Heart, Lung, and Blood Institute (N01-HC-025195, P50HL105185)
- National Institute of Diabetes and Digestive and Kidney Diseases (N01-HC-25195, R01DK031801, DK-31801, AG07181)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR45614, R01 AR/AG 41398, R01-AR35582, U01-AR45632, N01-AG-12100, U01 AR45647, U01AR045583, R01AR035584, R01AR35583, U01 AR-45583, AR45654, AR45614, U01-AR-45654, AR45647, AR35583, U01AR045580, AR-35584, AR 35582, AR45583, U01AR045632, U01AR045654, R01AR035582, U01AR045614, AR45580, AR/AG 41398, U01AR045647, R01AR035583, U01 AG18197, AR45632, R01‐AR‐35584, U01AR45580)
- National Center for Research Resources (U01 AR45654, RR-06192, U01 AR45632, M01RR006192, MO1 RR06192, U01 AR45580, U01 AR45647, UL1RR024140, U01 AR45614, U01 AR45583, U01 AG18197, RR024140)
- National Institute on Minority Health and Health Disparities (R01MD009164)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, muscle weakness, appendicular lean mass, grip strength, body mass index, diagnostic criteria, cut-off values, community-dwelling older adults, biomarkers
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Disease Susceptibility, Female, Humans, Male, National Institutes of Health (U.S.), Research Design, Risk Factors, Sex Factors, United States, Body Mass Index, Hand Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
